Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$280.2K
700.00 shares
What this filing means
MALCOLM JAN plans to sell 700.00 shares of UNITED THERAPEUTICS CORP valued at approximately $280.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2025ACC: 0001950047-25-006875
700.00
Shares to sell
$280.2K
Approx. market value
700.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
7/25/2025
590.00Restricted Stock
Not Applicable
6/26/2025
110.00Total acquired700.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/25/2025 | Restricted Stock Not Applicable | 590.00 | — |
6/26/2025 | Restricted Stock Not Applicable | 110.00 | — |
| Total | 700.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
700.00
Market value
$280.2K
9/9/2025
Total
Units
700.00
Value
$280.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/9/2025 | 700.00 | $280.2K | NASDAQ | Planned |
| Total | 700.00 | $280.2K | ||